Modulight Biotherapeutics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 23

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 11

Modulight Biotherapeutics General Information

Description

Developer of optogenetic therapy intended to treat neuronal overactivation disorders. The company's therapy harnesses endogenous cellular mechanisms to achieve synapse-level modulation with unprecedented spatiotemporal resolution, enabling medical professionals to transform the treatment of severe neurological conditions worldwide.

Contact Information

Website
www.modulight.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 501 Boylston Street
  • 10th floor
  • Boston, MA 02116
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 501 Boylston Street
  • 10th floor
  • Boston, MA 02116
  • United States
+1 (617)

Modulight Biotherapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Modulight Biotherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator 16-Apr-2026 Completed Pre-Clinical Trials
5. Secondary Transaction - Private 31-Mar-2026 Completed Pre-Clinical Trials
4. Seed Round 12-Nov-2025 Completed Pre-Clinical Trials
3. Accelerator/Incubator 16-Oct-2025 Completed Pre-Clinical Trials
2. Seed Round 08-Mar-2025 $4M $10.7M Completed Pre-Clinical Trials
1. Seed Round 01-Jun-2022 $6.7M $6.7M Completed Pre-Clinical Trials
To view Modulight Biotherapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Modulight Biotherapeutics Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 5

    Pending

  • Expiring in next 12 mo

Modulight Biotherapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4750528-A1 Treatment of diseases associated with pathologic neuronal cells Pending 27-Jul-2023
US-20260151511-A1 Treatment of diseases associated with pathologic neuronal cells Pending 27-Jul-2023
WO-2025022404-A1 Treatment of diseases associated with pathologic neuronal cells Inactive 27-Jul-2023
EP-4727642-A1 Controlling illumination and brain temperature in optogenetic activation Pending 14-Jun-2023
WO-2024256907-A1 Controlling illumination and brain temperature in optogenetic activation Inactive 14-Jun-2023 A61N1/3787
To view Modulight Biotherapeutics’s complete patent history, request access »

Modulight Biotherapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Modulight Biotherapeutics Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
ARC Innovation Center Accelerator/Incubator
BC Growth Equity Angel Group Minority
Fresh.Fund Venture Capital Minority
Redseed Venture Capital Minority
Saras Capital (England) Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

Modulight Biotherapeutics FAQs

  • When was Modulight Biotherapeutics founded?

    Modulight Biotherapeutics was founded in 2022.

  • Where is Modulight Biotherapeutics headquartered?

    Modulight Biotherapeutics is headquartered in Boston, MA.

  • What is the size of Modulight Biotherapeutics?

    Modulight Biotherapeutics has 23 total employees.

  • What industry is Modulight Biotherapeutics in?

    Modulight Biotherapeutics’s primary industry is Drug Discovery.

  • Is Modulight Biotherapeutics a private or public company?

    Modulight Biotherapeutics is a Private company.

  • What is Modulight Biotherapeutics’s current revenue?

    The current revenue for Modulight Biotherapeutics is .

  • How much funding has Modulight Biotherapeutics raised over time?

    Modulight Biotherapeutics has raised $22.9M.

  • Who are Modulight Biotherapeutics’s investors?

    ARC Innovation Center, BC Growth Equity, Fresh.Fund, Redseed, and Saras Capital (England) are 5 of 11 investors who have invested in Modulight Biotherapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process